Pain Department, A.O. Dei Colli - V. Monaldi Hospital, Napoli, Italy.
Università di Catania, Dipartimento di Scienze Biomediche e Biotecnologiche (BIOMETEC), Catania, Italy.
Neuromodulation. 2021 Jun;24(4):774-778. doi: 10.1111/ner.13265. Epub 2020 Sep 9.
Post-thoracotomy pain syndrome (PTPS) is defined as persistent pain following a thoracotomy and has an incidence of 21-61%. Dorsal root ganglion stimulation (DRG-S) is a form of neuromodulation that modulates pain signal transmission to the spinal cord. The aims of this study were to investigate the efficacy of DRG-S for the management of PTPS and to assess the role of thoracic paravertebral blocks (t-PVB) as a tool for prediction of success of DRG-S.
In this prospective study, we included all patients undergoing thoracic surgery, with PTPS not responding to pharmacotherapy and treated with DRG-S from September 2018 to February 2019. t-PVB followed by a percutaneous DRG-S trial was performed on all patients. Pain intensity was assessed through a numeric rating scale (NRS) and Douleur Neuropathique en 4 Questions (DN4) at baseline, post-trial, at 14 days, 90 days, and at one year after DRG-S implantation. Data summarized as continuous variables were expressed as means and standard deviations (SDs), and categorical variables were expressed as raw numbers and percentages.
Four patients out of 51 who underwent thoracic surgery at our institution surveyed were included (mean age ± SD, 56 ± 16 years old). Mean NRS and DN4 were, respectively, 7.2 ± 0.96 SD and 8.2 ± 0.5 SD at baseline, 2.5 ± 0.6 SD and 3.2 ± 0.5 SD after t-PVB, 2.2 ± 0.5 SD and 2.2 ± 0.5 SD at 14 days, 90 days, and at one year after DRG-S implantation. No complications or side effects were reported.
Our preliminary results show that DRG-S is an effective therapy for PTPS after thoracic surgery. In addition, thoracic paravertebral blocks performed prior to DRG-S correlated with a positive outcome with treatment.
开胸术后疼痛综合征(PTPS)定义为开胸术后持续疼痛,其发生率为 21-61%。背根神经节刺激(DRG-S)是一种神经调节形式,可调节疼痛信号向脊髓的传递。本研究的目的是探讨 DRG-S 治疗 PTPS 的疗效,并评估胸椎旁阻滞(t-PVB)作为预测 DRG-S 成功的工具的作用。
在这项前瞻性研究中,我们纳入了所有接受过胸部手术的患者,这些患者在药物治疗后仍有 PTPS,并接受了 DRG-S 治疗,时间为 2018 年 9 月至 2019 年 2 月。所有患者均行 t-PVB 后行经皮 DRG-S 试验。疼痛强度通过数字评分量表(NRS)和 4 个问题的神经性疼痛量表(DN4)进行评估,分别在基线、试验后、14 天、90 天和 DRG-S 植入后 1 年进行。总结为连续变量的数据用平均值±标准差(SD)表示,分类变量用原始数字和百分比表示。
在我们调查的 51 例接受胸部手术的患者中,有 4 例(平均年龄±SD,56±16 岁)纳入研究。NRS 和 DN4 的平均值分别为基线时的 7.2±0.96 SD 和 8.2±0.5 SD,t-PVB 后分别为 2.5±0.6 SD 和 3.2±0.5 SD,14 天、90 天和 DRG-S 植入后 1 年分别为 2.2±0.5 SD 和 2.2±0.5 SD。未报告任何并发症或副作用。
我们的初步结果表明,DRG-S 是治疗开胸术后 PTPS 的有效方法。此外,DRG-S 前进行的胸椎旁阻滞与治疗的良好结果相关。